IMARC Group's report titled “Bio-Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. offers a comprehensive analysis of the industry, which comprises insights on the global bio-implants market growth. The global market size reached US$ 117.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 189.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.12% during 2023-2028.

Bio-implants are specialized medical devices designed to be integrated into the human body for various therapeutic or cosmetic purposes. These implants are typically made from biocompatible materials like titanium, ceramic, or polymers to ensure compatibility with the body’s tissues and minimize the risk of rejection or adverse reactions. Bio-implants can serve a wide range of functions, including the replacement of damaged or degenerated body parts such as joints (hip, knee), dental implants, and cardiac stents. Additionally, bio-implants are used in reconstructive surgeries, tissue regeneration, and aesthetic procedures. These implants play a pivotal role in enhancing patients’ quality of life by restoring function and aesthetics while minimizing discomfort and recovery times.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/bio-implants-market/requestsample

Bio-Implants Market Trends and Drivers:

The aging population worldwide is driving the demand for orthopedic bio-implants, such as hip and knee replacements. As individuals seek to maintain an active lifestyle in their later years, the need for these implants is expected to grow steadily. Besides, continuous innovations in biomaterials, 3D printing, and tissue engineering are enhancing the performance and longevity of bio-implants. These advancements are increasing the success rates of implant surgeries and expanding the scope of applications. Moreover, chronic diseases like cardiovascular conditions and diabetes often require the use of bio-implants, such as cardiac stents or insulin pumps. As these diseases continue to rise globally, the demand for associated implants is also escalating. Additionally, aesthetic and dental bio-implants are gaining popularity, driven by a desire for improved appearance and dental health. This, coupled with advancements in cosmetic procedures, including breast augmentation and facial implants, are also contributing to market growth. Furthermore, the preference for minimally invasive surgical techniques is increasing, as they offer shorter recovery times and reduced scarring. Bio-implants designed for minimally invasive procedures, such as endoscopic surgery, are witnessing growing demand. Along with this, stringent regulatory requirements and quality standards are shaping the bio-implants market. Manufacturers are focusing on meeting these standards to gain trust among healthcare professionals and patients.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Type of Bio-Implants:

  • Cardiovascular Implants
  • Dental Implants
  • Spinal Bio-implants
  • Orthopaedic Implants
  • Ophthalmic Implants
  • Others

Breakup by Material:

  • Metallic
  • Ceramic
  • Polymer
  • Biological

Breakup by Origin:

  • Allograft
  • Autograft
  • Xenograft
  • Synthetic

Breakup by Mode of Administration:

  • Non-Surgical
  • Surgical

Breakup by End-User:

  • Ambulatory Surgical Centers
  • Clinics
  • Hospital
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Stryker Corporation
  • St. Jude Medical Inc
  • Medtronic Inc.
  • Smith and Nephew
  • Wright Medical Group
  • Zimmer Biomet
  • Dentsply Sirona
  • Invibio Limited
  • Straumann
  • Danaher Corporation
  • Cardinal Health
  • Johnson & Johnson
  • B. Braun Melsungen
  • LifeNet Health, Inc
  • Endo International plc.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal